physcione has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumontet, V; Guénard, D; Guéritte, F; Hill, B; Mai, LP; Sévenet, T; Thoison, O; Tri, MV | 1 |
| Arellano, ML; Boggon, TJ; Chen, J; Elf, S; Fan, J; Gaddh, M; Khoury, HJ; Khuri, FR; Lee, BH; Lin, R; Lonial, S; Pan, Y; Shan, C; Wu, S; Xia, S | 1 |
2 other study(ies) available for physcione and Leukemia
| Article | Year |
|---|---|
Cytotoxicity of Rhamnosylanthraquinones and Rhamnosylanthrones from Rhamnus nepalensis.
Topics: Animals; Anthraquinones; Antineoplastic Agents, Phytogenic; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; Fruit; Glycosides; Humans; KB Cells; Leukemia; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Molecular Structure; Plant Leaves; Plants, Medicinal; Rhamnaceae; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Vietnam | 2001 |
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
Topics: Animals; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cell Survival; Drug Synergism; Emodin; Female; Humans; K562 Cells; Leukemia; Mice; Mice, Nude; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Xenograft Model Antitumor Assays | 2017 |